Advertisements



We are Sorry, This Page doesn't Exist


Valeant launches $750 million bond offering, increases planned Term B loan borrowing

Valeant Pharmaceuticals International Inc. said T.....»»

Category: topSource: marketwatchMay 17th, 2018

Valeant (VRX) Rallies on Earnings Beat in Q1, Raises View

Valeant's (VRX) first-quarter earnings topped estimates driven by growth in Bausch + Lomb/International segment and Salix businesses. The company also upped its view. Shares of Valeant Pharmaceuticals.....»»

Category: dealsSource: nytMay 10th, 2018

Valeant will borrow more than $3.82 bln

Valeant Pharmaceuticals International Inc. said early Thursday that it plans to borrow an additional $3.815 billion of Term B loans and issue $750 million of secured debt securities and $750 million of unsecured debt securitie.....»»

Category: topSource: marketwatchMay 10th, 2018

Wednesday’s Vital Data: Valeant Pharmaceuticals Intl Inc (VRX), Walt Disney Co (DIS) and Citigroup Inc (C)

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Valeant (VRX) and Disney (.....»»

Category: topSource: investorplaceMay 9th, 2018

For the first time since 2015, we"re seeing organic growth: Valeant Pharma CEO

Jim Cramer sits down with Joseph Papa, the Chairman and CEO of Valeant Pharmaceuticals, after earnings......»»

Category: topSource: madmoneyMay 8th, 2018

Why Expeditors International of Washington, Valeant Pharmaceuticals International, and SeaWorld Entertainment Jumped Today

Find out which of these companies is changing its name -- and why......»»

Category: topSource: foxnewsMay 8th, 2018

Why Valeant Pharmaceuticals International Stock Is Moving Higher Today

The pace of Valeant's turnaround may be picking up......»»

Category: topSource: foxnewsMay 8th, 2018

Valeant Posts Q1 Earnings Beat, Announces Name Change To Bausch Health

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares were.....»»

Category: earningsSource: benzingaMay 8th, 2018

Valeant Pharmaceuticals International (VRX) Q1 2018 Results - Earnings Call Transcript

Valeant Pharmaceuticals International (VRX) Q1 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaMay 8th, 2018

Valeant Posts Q1 Earnings Beat, Announces Name Change To Bausch Health

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares were surging nearly 14 percent after the open Tuesday after the company reported first-quarter results and announced a name change to Bausch Health Companies Inc. read more.....»»

Category: blogSource: benzingaMay 8th, 2018

Embattled pharma company Valeant is changing its name as it seeks to revamp image (VRX)

Embattled pharma company Valeant Pharmaceuticals is changing its name to Bausch Health Companies as part of a .....»»

Category: topSource: businessinsiderMay 8th, 2018

What Will Become of Valeant Pharmaceuticals?

Valeant Pharmaceuticals released its most recent quarterly report and announced a name change before the markets opened on Tuesday......»»

Category: blogSource: 247wallstMay 8th, 2018

Valeant, a new business model and now, a new name

Valeant Pharmaceuticals, which came under heavy scrutiny for acquiring the rights to drugs and then drastically raising their prices, is changing its name......»»

Category: topSource: foxnewsMay 8th, 2018

Valeant Pharmaceuticals to Change Its Name to Bausch Health

Valeant plans to change its name to Bausch Health Cos., as management takes another step toward remaking the company and distancing it from past controversies......»»

Category: smallbizSource: wsjMay 8th, 2018

Valeant Stock Moves Higher After FDA Approves Bowel Cleanser

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares gained 2 percent Monday morning after the company confirmed the Food and Drug read more.....»»

Category: blogSource: benzingaMay 7th, 2018

Disney, Groupon, Nvidia and More Major Earnings Coming This Week

24/7 Wall St. has put together a preview of Disney, Nvidia, Valeant Pharmaceuticals and of some of the other top companies reporting their latest results in the coming week......»»

Category: blogSource: 247wallstMay 6th, 2018

Top Analyst Upgrades and Downgrades: ADM, Boeing, Hess, LogMeIn, NetApp, Sunrun, United Continental, Valeant, XPO and More

The top analyst upgrades, downgrades and other research calls from Friday include Archer Daniels Midland, Boeing, Hess, LogMeIn, NetApp, Sunrun, United Continental, Valeant Pharmaceuticals and XPO........»»

Category: blogSource: 247wallstApr 6th, 2018

Ionis Pharmaceuticals Larger Than S&P 500 Component Leggett & Platt

Market News Video.....»»

Category: topSource: redinewsMay 19th, 2018

Rocket Pharmaceuticals presents "encouraging" data from RP-L102 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 18th, 2018

Adamas Pharmaceuticals: Interesting Over The Long Term

Adamas Pharmaceuticals: Interesting Over The Long Term.....»»

Category: topSource: seekingalphaMay 18th, 2018